Bruker showcases high-performance solutions at Analytica 2024 for research and analysis in applied, industrial and biopharma laboratories

FHS
April 9, 2024
11:34 am

Bruker Corporation (Nasdaq: BRKR) is showcasing some of its latest innovations at Analytica 2024:

What to know about this summer’s landmark Wegovy heart health study

At some point this summer, the drugmaker Novo Nordisk will release results from a closely watched study that, if successful, could further uncork demand for

July 6, 2023

FDA says Philips’ testing of recalled devices is inadequate

Dive Brief: The Food and Drug Administration called for further testing by Philips to evaluate the risks of soundproofing foam used in its recalled sleep

October 6, 2023

Microbial biomarkers identified in lupus and IBD offer pathways for targeted therapies

Research connects gut microbiota to lupus and IBD, uncovering microbial markers and pathways that could inform targeted therapies for autoimmune disorders.

September 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.